STD-005-CREcRë · CHEMISTRY RESEARCH ENGINE (CRE)Medicinal Chemistry & Covalent Scaffolds

Latent Electrophile Scaffold Design for Covalent Cysteine Protease Inhibition

First-Principles Chemical Requirement Envelope Formulation & Challenger Falsification

X-Labs Sample Study · System Demonstration / Non-Customer StudyThis study was generated during X-Labs platform validation using a real-world scientific research problem. It demonstrates X-Labs research, scientific reasoning, evidence reconciliation, and/or engine-collaboration workflows. Scientific conclusions retain their recorded evidence status and should not be interpreted as experimentally validated unless specifically supported by physical experimental evidence.
Core Scientific Question
“Given what chemistry knows about reversible covalent warheads and nucleophilic thiolate addition, what chemically defensible latent electrophile scaffolds can achieve selective, context-dependent covalent labeling of catalytic cysteine residues without off-target plasma protein alkylation?”

CRE formulated an ab initio Chemical Requirement Envelope for targeting protease catalytic triads without systemic alkylation. By balancing the electrophilic reactivity window against the physiological pKa difference between catalytic thiolate (pKa < 6.5) and surface cysteines (pKa > 8.2), CRE mapped 2 divergent possibility branches. Branch 001 (alpha,beta-unsaturated cyanoacrylamide) survived first-principles scrutiny and RDKit conformational analysis. Branch 002 (unhindered alpha-bromoacetamide) was aggressively falsified and eliminated by Challenger review due to uncontrollable glutathione depletion.

Current Scientific AssessmentStatus: COMPUTATIONALLY PREDICTED
FND-005-01LEVEL 1 — PRINCIPLE SUPPORTEDTHEORETICALLY DERIVED

Active-site catalytic cysteine exhibits depressed pKa (5.5–6.2) due to His-imidazolium ion pairing, providing a ~100-fold nucleophilicity advantage over neutral surface cysteines (pKa > 8.0).

FND-005-02LEVEL 3 — COMPUTATIONALLY SUPPORTEDCOMPUTED

PROPRIETARY X-LABS SCIENTIFIC REASONING — WITHHELD FROM EXECUTIVE SAMPLE. Exact chemical kinetics and force-field parameters available under Controlled Disclosure.

FND-005-03LEVEL 4 — ADVERSARIALLY SURVIVEDTHEORETICALLY DERIVED

Unhindered direct SN2 alkylators exceed safe glutathione reactivity limits (> 10^3 M^-1 s^-1) and are eliminated on first principles (Baell & Walters, Nature 2014).

Need Full Chemical Envelopes & Unredacted Scaffolds?

Request Controlled Study Access to review unredacted chemical requirement envelopes and computational parameters.